Industries > Pharma > Global OTC Pharmaceutical Market Forecast 2018-2028

Global OTC Pharmaceutical Market Forecast 2018-2028

Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies

PUBLISHED: 05 April 2018
PAGES: 201
PRODUCT CODE: PHA0298

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 201-page report you will receive 84 tables and 79 figures– all unavailable elsewhere.

The 201-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global OTC Pharmaceutical Market forecasts from 2018-2028

• This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Global OTC Pharmaceutical Market Forecast 2018-2028

Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market

This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• GlaxoSmithKline (GSK) Consumer Care
• Perrigo Company PLC
• Johnson & Johnson
• Daiichi Sankyo Co., Ltd
• Pfizer Inc.
• Procter & Gamble
• Sanofi S.A
• Reckitt Benckiser Group PLC
• Cipla, Inc.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today Global OTC Pharmaceutical Market Forecast 2018-2028: Forecasts by Product (Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others) and Geography, with Analysis of Leading Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global OTC Pharmaceutical Market Forecast 2018-2028


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category